Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (1647)	11/9/1998 7:56:00 PM
From: rkrw	Read Replies (1) \| Respond to of 2742

Actually a 1 for 15 won't quite do it, assuming todays closing bid price of 23 cents. I see your point though, as the float would have to be 1M shares with a $4 bid price. They also need a $5M market value of the public float for listing. Note that those are requirements for a NASD Small Cap listing. You won't find many institutions willing to touch any stock with a 1M share float and a market valuation of roughly $5M. If you are correct that institutions would be willing to take stakes, the result would be even less liquidity. Todays spread is 3 cents, or 13%, which would be the equivalent of roughly $1.75 x $2.00. Maybe Cist can use that $300,000 in annual funding from Rhone Poulenc and come up with some meaningful data that will set the stock aflame. I take it you and Dr DeCastro believe a primary reason for the shares discount to cash value lies in where it trades. My personal view is that fair value lies somewhere around cash on hand and a listing is inconsequential for now. I also see no reason why Cist wouldn't follow the norm and selloff upon a reverse split.